title: Pro: Inhaled Pulmonary Vasodilators Should Be Used Routinely in the Management of Patients Undergoing Lung Transplantation.
authors.affiliation: Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Sujatha
authors.initials: S
authors.lastname: Bhandary
authors.affiliation: Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Nicoleta
authors.initials: N
authors.lastname: Stoicea
authors.affiliation: Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, OH; Department of Neuroscience, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Joseph
authors.affiliation: Department of Cardiac Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
authors.forename: Bryan
authors.initials: B
authors.lastname: Whitson
authors.affiliation: Department of Anesthesiology, The Ohio State University Wexner Medical Center, Columbus, OH. Electronic address: Michael.Essandoh@osumc.edu.
authors.forename: Michael
authors.initials: M
authors.lastname: Essandoh
mesh_terms: D000280:Administration, Inhalation; D019468:Disease Management; D006801:Humans; D016040:Lung Transplantation / Q000009:adverse effects / Q000379:methods*; D009569:Nitric Oxide / Q000008:administration & dosage; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D009569:Nitric Oxide
keywords: epoprostenol; lung transplantation; nitric oxide; primary graft dysfunction; pulmonary hypertension; right ventricular dysfunction